Every SEC Form 3/4/5 on record for this filer (CIK 1202335) — 8 issuers, 96 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | Director | 2026-06-15 → 2026-06-15 | 1 | — |
| FBRX | Forte Biosciences, Inc. | Director | 2023-01-12 → 2026-06-02 | 7 | — |
| MNMD | Mind Medicine (MindMed) Inc. | Director | 2023-06-23 → 2025-06-16 | 6 | $38,855 |
| SGEN | Seagen Inc. | Director · lapsed | 2015-11-05 → 2023-12-15 | 23 | −$9M |
| AERI | AERIE PHARMACEUTICALS INC | Director · lapsed | 2018-09-12 → 2022-11-21 | 7 | — |
| GWPH | GW PHARMACEUTICALS PLC | Director · lapsed | 2020-09-16 → 2021-05-07 | 4 | — |
| PDLI | PDL BIOPHARMA, INC. | Director · lapsed | 2016-06-03 → 2020-12-31 | 12 | −$925,800 |
| INCY | INCYTE CORP | Executive Vice President, CFO · lapsed | 2016-01-08 → 2018-07-18 | 15 | −$9M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| MNMD | 2024-12-05 | Buy | 2,500 | $7.17 | $17,925 | 19,851 |
| MNMD | 2024-08-23 | Buy | 3,500 | $5.98 | $20,930 | 17,351 |
3 of 8 issuers are covered and open a security page; the rest are on file here only.
